About
Human Reovirus Delivery
Areas of Focus
Categories
Biologics & BiopharmaceuticalVirus TechnologyDrug Delivery & Formulation
Clinical Trials (21)
View allTotal Trials
21
As Lead Sponsor
13
As Collaborator
8
Total Enrollment
997
By Phase
PHASE2: 12EARLY_PHASE1: 1PHASE1: 7PHASE3: 1
By Status
COMPLETED: 16ACTIVE_NOT_RECRUITING: 2TERMINATED: 1UNKNOWN: 1WITHDRAWN: 1
Clinical Trials Pipeline21 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT04445844Collaborator
INCMGA00012 and Pelareorep for the Treatment of Metastatic Triple Negative Breast Cancer, IRENE Study
PHASE2Active, not recruiting
25 participants
Started: Jul 13, 2020 · Completed: Jun 30, 2025
NCT04215146Lead Sponsor
A Study to Assess Overall Response Rate by Inducing an Inflammatory Phenotype in Metastatic BReast cAnCEr With the Oncolytic Reovirus PeLareorEp in CombinaTion With Anti-PD-L1 Avelumab and Paclitaxel - BRACELET-1 Study
PHASE2Active, not recruiting
48 participants
Started: Jun 10, 2020 · Completed: Jun 30, 2025
NCT04102618Lead Sponsor
A Window-of-opportunity Study of Pelareorep in Early Breast Cancer
EARLY_PHASE1Terminated
26 participants
Started: Mar 29, 2019 · Completed: Apr 20, 2022
NCT03605719Collaborator
Dexamethasone, Carfilzomib, & Nivolumab With Pelareorep for Relapsed/Refractory Multiple Myeloma
PHASE1Completed
23 participants
Started: Oct 24, 2018 · Completed: Oct 10, 2022
NCT03015922Collaborator
Viral Immunotherapy in Relapsed/Refractory Multiple Myeloma
PHASE1Unknown
4 participants
Started: Jun 5, 2017 · Completed: Oct 1, 2021
Locations (1)
Headquarters
Calgary, AB, Canada
Map
Loading map...